As recommended in the Wegovy PIL, rotate within and between approved regions, avoiding using the exact same spot consecutively
GLP-1 GLP-1-1 GLP-1GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 3 GLP-1FDAEU28 GLP-1 GLP-1 GLP-130 GLP-1 GLP-1 GLP-1 10.30.30.60.9 0.6/18130 0.9/18120 1.8/18110 36 283028 12.5mg415mg15mg442.5mg115mg 120ml () webGLP 1,100 GLP-1 GLP-12 FDAMFDSEU27EMA 0.6/18130 0.9/18120 1.8/18110 4 418
[DOI] [PubMed] [Google Scholar] [33].Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, Butterfield DA
Vomiting was reported by 24% of the patients, diarrhea by 30%, constipation 24%, abdominal pain 20%, headache 14%, fatigue (tiredness) 11%, indigestion 9%, dizziness 8%, abdominal bloating 7%, flatulence 6%, loud burping 7%, low blood sugar (hypoglycemia) 6% and other side effects